18552311000001103: Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)
\UK product\Virtual medicinal product\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing phosphorus and/or phosphorus compound (product)\Product containing bisphosphonate\Product containing risedronic acid\Product containing only risedronic acid (medicinal product)\Product containing only risedronic acid in oral dose form (medicinal product form)\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing phosphorus and/or phosphorus compound (product)\Product containing bisphosphonate\Product containing risedronic acid\Product containing risedronic acid in oral dose form (medicinal product form)\Product containing only risedronic acid in oral dose form (medicinal product form)\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing risedronic acid in oral dose form (medicinal product form)\Product containing only risedronic acid in oral dose form (medicinal product form)\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)
\Medicinal product\Product containing bone resorption inhibitor\Product containing bisphosphonate\Product containing risedronic acid\Product containing only risedronic acid (medicinal product)\Product containing only risedronic acid in oral dose form (medicinal product form)\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)
\Medicinal product\Product containing bone resorption inhibitor\Product containing bisphosphonate\Product containing risedronic acid\Product containing risedronic acid in oral dose form (medicinal product form)\Product containing only risedronic acid in oral dose form (medicinal product form)\Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet\Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Mar 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

63655601000001119 Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

63655701000001112 Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	Is a	Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	Has active ingredient	Risedronate sodium	false	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	Has specific active ingredient	Risedronate sodium	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd) 4 tablet	Has AMP	True	Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
63655601000001119	Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
63655701000001112	Risedronate sodium 35mg tablets (Ranbaxy (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module